These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 38415252)
1. Unveiling the immune symphony: decoding colorectal cancer metastasis through immune interactions. He R; Huang S; Lu J; Su L; Gao X; Chi H Front Immunol; 2024; 15():1362709. PubMed ID: 38415252 [TBL] [Abstract][Full Text] [Related]
2. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer. Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779 [TBL] [Abstract][Full Text] [Related]
4. Colorectal Cancer-Derived Small Extracellular Vesicles Promote Tumor Immune Evasion by Upregulating PD-L1 Expression in Tumor-Associated Macrophages. Yin Y; Liu B; Cao Y; Yao S; Liu Y; Jin G; Qin Y; Chen Y; Cui K; Zhou L; Bian Z; Fei B; Huang S; Huang Z Adv Sci (Weinh); 2022 Mar; 9(9):2102620. PubMed ID: 35356153 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer. Chen QY; Chen YX; Han QY; Zhang JG; Zhou WJ; Zhang X; Ye YH; Yan WH; Lin A Front Immunol; 2021; 12():679090. PubMed ID: 34054869 [TBL] [Abstract][Full Text] [Related]
6. The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer. Subtil B; Cambi A; Tauriello DVF; de Vries IJM Front Immunol; 2021; 12():724883. PubMed ID: 34691029 [TBL] [Abstract][Full Text] [Related]
7. How to overcome tumor resistance to anti-PD-1/PD-L1 therapy by immunotherapy modifying the tumor microenvironment in MSS CRC. Chen L; Jiang X; Li Y; Zhang Q; Li Q; Zhang X; Zhang M; Yu Q; Gao D Clin Immunol; 2022 Apr; 237():108962. PubMed ID: 35227870 [TBL] [Abstract][Full Text] [Related]
8. Immune Adaptation of Colorectal Cancer Stem Cells and Their Interaction With the Tumor Microenvironment. Lin CC; Liao TT; Yang MH Front Oncol; 2020; 10():588542. PubMed ID: 33312953 [TBL] [Abstract][Full Text] [Related]
9. The tumor microenvironment of colorectal cancer metastases: opportunities in cancer immunotherapy. Kamal Y; Schmit SL; Frost HR; Amos CI Immunotherapy; 2020 Oct; 12(14):1083-1100. PubMed ID: 32787587 [TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for colorectal cancer: Rational strategies and novel therapeutic progress. Rastin F; Javid H; Oryani MA; Rezagholinejad N; Afshari AR; Karimi-Shahri M Int Immunopharmacol; 2024 Jan; 126():111055. PubMed ID: 37992445 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of colorectal liver metastasis development. Shasha T; Gruijs M; van Egmond M Cell Mol Life Sci; 2022 Nov; 79(12):607. PubMed ID: 36436127 [TBL] [Abstract][Full Text] [Related]
12. Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer. Rizzo G; Bertotti A; Leto SM; Vetrano S J Exp Clin Cancer Res; 2021 Jun; 40(1):178. PubMed ID: 34074330 [TBL] [Abstract][Full Text] [Related]
13. The Role of Tumor Microenvironment Cells in Colorectal Cancer (CRC) Cachexia. Kasprzak A Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557173 [TBL] [Abstract][Full Text] [Related]
14. Microsatellite Instability and Immune Response: From Microenvironment Features to Therapeutic Actionability-Lessons from Colorectal Cancer. Greco L; Rubbino F; Dal Buono A; Laghi L Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372349 [TBL] [Abstract][Full Text] [Related]
16. Cancer-Associated Fibroblasts Promote the Upregulation of PD-L1 Expression Through Akt Phosphorylation in Colorectal Cancer. Gao Y; Sun Z; Gu J; Li Z; Xu X; Xue C; Li X; Zhao L; Zhou J; Bai C; Han Q; Zhao RC Front Oncol; 2021; 11():748465. PubMed ID: 34868949 [TBL] [Abstract][Full Text] [Related]
18. Immunotherapy and immunoevasion of colorectal cancer. Al Zein M; Boukhdoud M; Shammaa H; Mouslem H; El Ayoubi LM; Iratni R; Issa K; Khachab M; Assi HI; Sahebkar A; Eid AH Drug Discov Today; 2023 Sep; 28(9):103669. PubMed ID: 37328052 [TBL] [Abstract][Full Text] [Related]
19. Integrin-Linked Kinase Expression Characterizes the Immunosuppressive Tumor Microenvironment in Colorectal Cancer and Regulates PD-L1 Expression and Immune Cell Cytotoxicity. Almasabi S; Boyd R; Ahmed AU; Williams BRG Front Oncol; 2022; 12():836005. PubMed ID: 35692780 [TBL] [Abstract][Full Text] [Related]
20. TMEM160 promotes tumor immune evasion and radiotherapy resistance via PD-L1 binding in colorectal cancer. Dai X; Wu Z; Ruan R; Chen J; Huang C; Lei W; Yao Y; Li L; Tang X; Xiong J; Feng M; Deng J Cell Commun Signal; 2024 Mar; 22(1):168. PubMed ID: 38454413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]